Method for the treatment of eosinophil-associated conditions with anionic polymers
US5498410A · kind A · utility
11Cited by
14References
11Claims
0Family size
Inventor
Key dates
| Filing date | Sep 30, 1993 |
| Grant date | Mar 12, 1996 |
| Priority date | — |
| Expiry date | Sep 30, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method is provided for treating a hypersensitivity disease comprising parenterally administering to a human afflicted with such a disease an amount of an anionic polymer effective to counteract the symptoms of a disease selected from the group consisting of bronchial asthma, eosinophil-associated nasal inflammation and vernal conjunctivitis, by counteracting the effect of at least one cationic toxin released by the eosinophils of said human.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.